Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia
DSIJ Intelligence / 24 Aug 2017
Engaged in developing formulations and active pharmaceutical ingredients (API), Alembic Pharma has sold its formulations’ manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL).
Engaged in developing formulations and active pharmaceutical ingredients (API), Alembic Pharma has sold its formulations’ manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL).
SEPL does not belong to the promoter or promoter group or group companies and is not related party of the company. Alembic Pharma continues to meet its domestic formulation demand from its Sikkim unit and international formulation demand from its Panelav unit.
The share price of Alembic Pharma was trading at Rs 515.70, up by 1.99% in the pre-market session on Thursday at 0952 hours. The stock has witnessed turnover of Rs 7 lakh and turnover quantity of 1,358 on the BSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.